Pharmaceuticals Global On demand · 24-48h

Global Evening Primrose Oil Softgels Market Strategic Research Report

Global Evening Primrose Oil Softgels Market Strategic Resear…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Evening Primrose Oil Softgels Market
$9452025
6.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: 7 % GLA Softgel, 10 % GLA Softgel, High-GLA 12 % Softgel, Others

By Application: Women’s Health Support, Skin Moisturizing, Hormone Balance Regulation, Immune Support

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Swisse, Blackmores, JAMIESON, Nutrition29, GNC, Srgohealth, Bill Beauty & Health Products, Zeinpharma, CAMETTE, AUSupreme, PURITAN'S Pride

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 110 pages
Market size 2025
$945
Million USD
Forecast CAGR
6.3%
2025-2032
Forecast 2032
$1449.3
Projected
영역들
5
Asia Pacific · Latin America · MEA · Europe · North America

개요

Scope of the Report

The global Evening Primrose Oil Softgels market size is predicted to grow from US$ 945 million in 2025 to US$ 1,440 million in 2032; it is expected to grow at a CAGR of 6.3% from 2026 to 2032.

In 2024, the global annual production capacity of evening primrose oil softgels was approximately 95 million bottles, while the actual output reached around 80 million bottles. The average global market price was about US$11.5 per bottle, and the gross profit margin for major manufacturers ranged between 35% and 50%. Evening Primrose Oil softgels are dietary supplements extracted from the seeds of the evening primrose plant. They are rich in gamma-linolenic acid (GLA), an omega-6 fatty acid known for supporting hormonal balance, skin health, and overall wellness.

Upstream includes evening primrose seed cultivation, cold-press oil extraction, gelatin capsule production, and refined GLA concentrates. Midstream consists of supplement manufacturers, softgel encapsulation plants, and OEM/ODM nutrition factories. Downstream includes pharmacies, supermarkets, e-commerce platforms, health stores, and nutraceutical distributors. End users focus on purity (GLA content), certifications, supply stability, and product safety.

The Evening Primrose Oil softgel market continues to grow due to increasing consumer awareness of women's health, hormonal balance, and natural supplements. Rising demand for preventive healthcare and skin-care related nutrition strongly supports product adoption. Manufacturers are improving GLA extraction efficiency and adopting cold-press methods to enhance product purity and stability. E-commerce channels, especially in Asia-Pacific and North America, are accelerating market penetration. Regulatory emphasis on product quality and traceability is also reshaping the competitive landscape. As clean-label supplements gain popularity, brands are shifting toward non-GMO, organic-certified, and sustainably sourced evening primrose oil.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Evening Primrose Oil Softgels market?

What factors are driving Evening Primrose Oil Softgels market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Evening Primrose Oil Softgels market opportunities vary by end market size?

How does Evening Primrose Oil Softgels break out by Type, by Application?

This report presents a comprehensive overview of the global Evening Primrose Oil Softgels market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • 7 % GLA Softgel
  • 10 % GLA Softgel
  • High-GLA 12 % Softgel
  • Others

Segment by Capsule Type

  • Softgel Capsules
  • Vegetarian Softgel Capsules
  • Enteric-Coated Capsules
  • Others

Segment by Application

  • Women’s Health Support
  • Skin Moisturizing
  • Hormone Balance Regulation
  • Immune Support

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Evening Primrose Oil Softgels market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Women’s Health Support, Skin Moisturizing, Hormone Balance Regulation evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Evening Primrose Oil Softgels Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$945
2025
Forecast
$1449.3
2032
CAGR
6.3%
2025–2032
영역들
5
global
Key companies
SwisseBlackmoresJAMIESONNutrition29GNCSrgohealthBill Beauty & Health ProductsZeinpharma
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
7 % GLA Softgel10 % GLA SoftgelHigh-GLA 12 % SoftgelOthers
By Application
Women’s Health SupportSkin MoisturizingHormone Balance RegulationImmune Support

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 7 % GLA Softgel
  • 3.1.3 10 % GLA Softgel
  • 3.1.4 High-GLA 12 % Softgel
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Women’s Health Support
  • 4.1.3 Skin Moisturizing
  • 4.1.4 Hormone Balance Regulation
  • 4.1.5 Immune Support
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Swisse
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Blackmores
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 JAMIESON
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Nutrition29
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 GNC
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Srgohealth
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Bill Beauty & Health Products
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Zeinpharma
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 CAMETTE
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 AUSupreme
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 PURITAN'S Pride
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Evening Primrose Oil Softgels market?
The global Evening Primrose Oil Softgels market is estimated at US$ 945 million in 2025 (base year) and is projected to reach US$ 1.44 billion by 2032.
What is the forecast CAGR for the Evening Primrose Oil Softgels market?
The market is expected to grow at a CAGR of 6.3% from 2026 to 2032, expanding from US$ 945 million in 2025 to US$ 1.44 billion in 2032, roughly 1.5 times its base-year value.
What is Evening Primrose Oil Softgels?
In 2024, the global annual production capacity of evening primrose oil softgels was approximately 95 million bottles, while the actual output reached around 80 million bottles. The average global market price was about US$11.5 per bottle, and the gross profit margin for major manufacturers ranged between 35% and 50%. Evening Primrose Oil softgels are dietary supplements extracted from the seeds of the evening primrose plant.
What are the main segments of the Evening Primrose Oil Softgels market by type?
By type, the market is segmented into 7 % GLA Softgel, 10 % GLA Softgel, High-GLA 12 % Softgel and Others.
Which applications drive demand in the Evening Primrose Oil Softgels market?
Key applications covered include Women’s Health Support, Skin Moisturizing, Hormone Balance Regulation and Immune Support.
Who are the key players in the Evening Primrose Oil Softgels market?
Key players profiled include Swisse, Blackmores, JAMIESON, Nutrition29, GNC, Srgohealth, Bill Beauty & Health Products and Zeinpharma, among 11 companies covered in total.
Which regions and countries are covered for Evening Primrose Oil Softgels?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Evening Primrose Oil Softgels market?
What factors are driving Evening Primrose Oil Softgels market growth, globally and by region?
Who should buy the Evening Primrose Oil Softgels market report?
The report is intended for manufacturers and solution providers, distributors and end users in Women’s Health Support, Skin Moisturizing and Hormone Balance Regulation, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Evening Primrose Oil Softgels market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.